Mirum Pharmaceuticals (MIRM) Q3 2021 Earnings Report
MX:MIRM Q3 2021 EPS Results
- Actual EPS
- -MXN 29.13
- Consensus EPS
- -MXN 32.59
- Beat/Miss
- Beat by +MXN 3.46
- One Year Ago EPS
- -MXN 16.16
MX:MIRM Q3 2021 Revenue Results
- Actual Revenue
- MXN 93.96M
- Expected Revenue
- MXN 18.79M
- Beat/Miss
- Beat by +MXN 75.17M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/15/2021
- Time
- After Close
- Conference Call
- Monday, November 15, 2021
MX:MIRM Upcoming Earnings
Mirum Pharmaceuticals's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:MIRM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | -9.15- | 0.94 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -13.96-19.92 | -2.26 | -783.33% (-17.66) | |
| May 06, 2026 | 2026 (Q1) | -6.86-252.38 | -5.64 | -4376.67% (-246.74) | |
| Feb 25, 2026 | 2025 (Q4) | 1.05-1.88 | -9.21 | 79.59% (+7.33) | |
| Nov 04, 2025 | 2025 (Q3) | -2.630.94 | -5.64 | 116.67% (+6.58) | |
| Aug 06, 2025 | 2025 (Q2) | -6.13-2.26 | -9.77 | 76.92% (+7.52) | |
| May 07, 2025 | 2025 (Q1) | -6.20-5.64 | -10.15 | 44.44% (+4.51) | |
| Feb 26, 2025 | 2024 (Q4) | -4.85-9.21 | -11.84 | 22.22% (+2.63) | |
| Nov 12, 2024 | 2024 (Q3) | -8.44-5.64 | -10.71 | 47.37% (+5.07) | |
| Aug 07, 2024 | 2024 (Q2) | -8.87-9.77 | -36.46 | 73.20% (+26.68) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed